John W. Kebabian

12.0k total citations · 4 hit papers
95 papers, 9.8k citations indexed

About

John W. Kebabian is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, John W. Kebabian has authored 95 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 61 papers in Cellular and Molecular Neuroscience and 8 papers in Physiology. Recurrent topics in John W. Kebabian's work include Receptor Mechanisms and Signaling (59 papers), Neurotransmitter Receptor Influence on Behavior (36 papers) and Neuroscience and Neuropharmacology Research (32 papers). John W. Kebabian is often cited by papers focused on Receptor Mechanisms and Signaling (59 papers), Neurotransmitter Receptor Influence on Behavior (36 papers) and Neuroscience and Neuropharmacology Research (32 papers). John W. Kebabian collaborates with scholars based in United States, United Kingdom and Czechia. John W. Kebabian's co-authors include Donald B. Calne, J.C. Stoof, Paul Greengard, Gary L. Petzold, C. E. Thomas, Robert L. Eskay, C. W. GREWE, K. Tsuruta, Yvonne C. Clement‐Cormier and Juan M. Saavedra and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

John W. Kebabian

95 papers receiving 9.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multiple receptors for dopamine

1979 3.1k citations John W. Kebabian, Donald B. Calne Nature profile →
Two dopamine receptors: Biochemistry, physiology and pharmacology

1984 841 citations John W. Kebabian et al. profile →
Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the “dopamine receptor”

1972 772 citations John W. Kebabian, Gary L. Petzold et al. Proceedings of the National Academy of Sciences profile →
Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

1981 765 citations John W. Kebabian et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John W. Kebabian United States	40	6.8k	5.7k	1.1k	973	719	95	9.8k
Marie‐Pascale Martres France	45	7.6k 1.1×	5.9k 1.0×	1.1k 1.0×	750 0.8×	1.2k 1.7×	84	10.3k
Frederick J. Monsma United States	47	8.9k 1.3×	8.0k 1.4×	1.2k 1.2×	1.7k 1.8×	520 0.7×	83	13.0k
Hyman B. Niznik Canada	47	7.3k 1.1×	5.5k 1.0×	1.6k 1.5×	645 0.7×	1.5k 2.1×	103	11.0k
Mark R. Brann United States	49	6.4k 0.9×	7.8k 1.4×	546 0.5×	640 0.7×	454 0.6×	112	10.3k
G. Jönsson Sweden	58	6.3k 0.9×	3.3k 0.6×	1.5k 1.4×	1.8k 1.8×	469 0.7×	180	10.6k
L.F. Agnati Italy	51	4.9k 0.7×	4.0k 0.7×	647 0.6×	1.1k 1.1×	252 0.4×	230	8.6k
Pierre M. Laduron Belgium	43	5.5k 0.8×	4.9k 0.9×	448 0.4×	1.1k 1.1×	551 0.8×	177	8.3k
Jean‐Charles Schwartz France	63	7.3k 1.1×	8.3k 1.5×	850 0.8×	1.6k 1.6×	783 1.1×	221	15.4k
Guadalupe Mengod Spain	56	6.7k 1.0×	5.3k 0.9×	960 0.9×	879 0.9×	522 0.7×	177	9.9k
M. Goldstein United States	50	6.6k 1.0×	4.4k 0.8×	731 0.7×	1.6k 1.7×	361 0.5×	164	9.1k

Countries citing papers authored by John W. Kebabian

Since Specialization

Citations

This map shows the geographic impact of John W. Kebabian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Kebabian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Kebabian more than expected).

Fields of papers citing papers by John W. Kebabian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Kebabian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Kebabian. The network helps show where John W. Kebabian may publish in the future.

Co-authorship network of co-authors of John W. Kebabian

This figure shows the co-authorship network connecting the top 25 collaborators of John W. Kebabian. A scholar is included among the top collaborators of John W. Kebabian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. Kebabian. John W. Kebabian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kula, Nora S., et al.. (1997). RBI-257: A highly potent dopamine D4 receptor-selective ligand. European Journal of Pharmacology. 331(2-3). 333–336. 28 indexed citations

Steffey, Michael E., Ellen Roberts, Donald E. Frail, John W. Kebabian, & Robert G. MacKenzie. (1993). Further characterization of the D2 dopamine receptor expressed in MMQ cells. Biochemical Pharmacology. 46(4). 747–751. 7 indexed citations

Kebabian, John W.. (1993). Brain dopamine receptors: 20 Years of progress. Neurochemical Research. 18(1). 101–104. 8 indexed citations

Britton, Donald R., John W. Kebabian, & Peter Curzon. (1991). Rapid reversal of denervation supersenssitivity of dopamine D1 receptors by 1-dopa or a novel dopamamine D1 receptor agonist, A68930. European Journal of Pharmacology. 200(1). 89–93. 19 indexed citations

Britton, Donald R., Peter Curzon, Robert G. MacKenzie, et al.. (1991). Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacology Biochemistry and Behavior. 39(4). 911–915. 80 indexed citations

DeNinno, Michael P., Robert Schoenleber, Richard J. Perner, et al.. (1991). Synthesis and dopaminergic activity of 3-substituted 1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-1H-2-benzopyrans: characterization of an auxiliary binding region in the D1 receptor. Journal of Medicinal Chemistry. 34(8). 2561–2569. 55 indexed citations

DeNinno, Michael P., Robert Schoenleber, Karen E. Asin, Robert G. MacKenzie, & John W. Kebabian. (1990). (1R,3S)-1-(Aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2-benzopyran: a potent and selective D1 agonist. Journal of Medicinal Chemistry. 33(11). 2948–2950. 40 indexed citations

Rao, Donald D., et al.. (1990). Two forms of the rat D₂ dopamine receptor as revealed by the polymerase chain reaction. FEBS Letters. 263(1). 18–22. 39 indexed citations

Sidhu, Anita & John W. Kebabian. (1985). An iodinated ligand identifying the D-1 dopamine receptor. European Journal of Pharmacology. 113(3). 437–440. 62 indexed citations

10.

Kebabian, John W., Jean‐Martin Beaulieu, & Yoshiharu Itoh. (1984). Pharmacological and Biochemical Evidence for the Existence of Two Categories of Dopamine Receptor. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 11(S1). 114–117. 59 indexed citations

11.

Goldman, Mark E., Jean‐Martin Beaulieu, John W. Kebabian, & Robert L. Eskay. (1983). α-Melanocyte-Stimulating Hormone-Like Peptides in the Intermediate Lobe of the Rat Pituitary Gland: Characterization of Content and Release in Vitro. Endocrinology. 112(2). 435–441. 39 indexed citations

12.

Thomas, C. E., C. W. GREWE, & John W. Kebabian. (1982). Guanyl Nucleotides Participate in the Β-Adrenergic Stimulation of Adenylate Cyclase Activity in the Intermediate Lobe of the Rat Pituitary Gland. Endocrinology. 110(3). 805–811. 19 indexed citations

13.

Brown, Eric, et al.. (1980). Characterization of Dopaminergic Receptors in Dispersed Bovine Parathyroid Cells. Molecular Pharmacology. 18(3). 335–340. 30 indexed citations

14.

Munemura, M, et al.. (1980). The Dopamine Receptor in the Intermediate Lobe of the Rat Pituitary Gland: Pharmacological Characterization. Endocrinology. 107(6). 1676–1683. 131 indexed citations

15.

Kebabian, John W. & Donald B. Calne. (1979). Multiple receptors for dopamine. Nature. 277(5692). 93–96. 3080 indexed citations breakdown →

16.

Kebabian, John W., Juan M. Saavedra, & J Axelrod. (1977). A SENSITIVE ENZYMATIC‐RADIOISOTOPIC ASSAY FOR 3,4‐DIHYDROXYPHENYLACETIC ACID. Journal of Neurochemistry. 28(4). 795–801. 29 indexed citations

17.

Kizer, John S., Miklós Palkovits, Marcel Tappaz, John W. Kebabian, & M J Brownstein. (1976). Distribution of Releasing Factors, Biogenic Amines, and Related Enzymes in the Bovine Median Eminence. Endocrinology. 98(3). 685–695. 38 indexed citations

18.

Kebabian, John W., Alton L. Steiner, & Paul Greengard. (1975). Muscarinic cholinergic regulation of cyclic guanosine 3,5-monophosphate in autonomic ganglia: possible role in synaptic transmission.. Journal of Pharmacology and Experimental Therapeutics. 193(2). 474–488. 85 indexed citations

19.

Kebabian, John W., Gary L. Petzold, & Paul Greengard. (1972). Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the “dopamine receptor”. Proceedings of the National Academy of Sciences. 69(8). 2145–2149. 772 indexed citations breakdown →

20.

Kebabian, John W. & Paul Greengard. (1971). Dopamine-Sensitive Adenyl Cyclase: Possible Role in Synaptic Transmission. Science. 174(4016). 1346–1349. 323 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact